Surgical Nivolumab And Ipilimumab For Recurrent GBM
Status:
Recruiting
Trial end date:
2023-12-31
Target enrollment:
Participant gender:
Summary
This research trial is studying the safety and effectiveness of nivolumab in combination with
ipilimumab and surgery when used in the treatment of recurrent glioblastoma.
The names of the study drugs involved in this study are:
- Nivolumab
- Ipilimumab
- Placebo (IV solution with no medicine)
- 89Zr-Df-IAB22M2C (optional sub-study)